This study focuses on China's Anti Dermatomycosis Skin Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. Rapid consolidation between medium and large players is anticipated since the Chinese government has been encouraging industry consolidation with an effort to regulate the industry and to improve competitiveness in the world market.
Although China has enjoyed the benefits of an expanding market for production and distribution, the industry is suffering from minimal innovation and investment in R&D and new product development. The sector's economies of scale have yet to be achieved. Most domestic manufacturers lack the autonomic intellectual property and financial resources to develop their own brand name products.
This new study focuses on industry trends and forecasts with historical data (2010, 2015 and 2020) and long-term forecasts through 2025 and 2030 are presented.
The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases.
Asia Market Info & Dev Co. is one of the leading sources for up-to-date market information and research on the fastest-growing Chinese markets. We have published over 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our publications are intended to help international marketers identify business opportunities and promote their product sales in the Chinese markets.
TABLE OF CONTENTS
I. INTRODUCTION
- Report Scope and Methodology
- Executive Summary
II. BUSINESS ENVIRONMENT
- Economic Outlook
- Key Economic Indicators
- Industrial Output
- Population and Labor
- Foreign Investment
- Foreign Trade
- Financial and Tax Regulations
- Banking System and Regulations
- Foreign Exchange
- Taxes, Tariff and Custom Duties
III. ANTI DERMATOMYCOSIS SKIN DRUGS INDUSTRY ASSESSMENTS
- Anti Dermatomycosis Skin Drugs Industry Structure
- Market Size
- Market Growth Driver
- Anti Dermatomycosis Skin Drugs Sales Volume
- Major Producer Facility Locations and Sales Volume
- Market Share of Key Producers
- Labor Cost
- Potential Entrants
- Major Distributors
- Major Foreign Investments
- Technology Development
IV. ANTI DERMATOMYCOSIS SKIN DRUGS PRODUCTION AND DEMAND
- Overview
- Demand of Anti Dermatomycosis Skin Drugs by Region
- Anti Dermatomycosis Skin Drugs Sales Volume
- Fluconazole Sales Volume and Market Share
- Itraconazole Sales Volume and Market Share
- Terbinafine Sales Volume and Market Share
- Econazole Sales Volume and Market Share
- Miconazole Nitrate Sales Volume and Market Share
- Amphotericin B Sales Volume and Market Share
- Ketoconazole Sales Volume and Market Share
- Clotrimazole Sales Volume and Market Share
- Caspofungin Sales Volume and Market Share
- Other Anti Dermato Mycosis Skin Drugs Sales Volume and Market Share
- Anti Dermatomycosis Skin Drugs Imports and Exports
- Pricing Trends
V. ANTI DERMATOMYCOSIS SKIN DRUGS MARKET OUTLOOK
- Anti Dermatomycosis Skin Drugs Markets Outlook Overview Concrete Government Regulations
- Health Care Insurance Industry Overview
- Consumer Spending Trends
- Northeast
- North
- Southeast
- Central
- Southwest
- Northwest
- Demographic Trends
- Health Care Industry Trends
- Hospitals and Hospital Beds
VI. MARKET ENTRY CHANNELS
- China Market Entry Overview
- China's Distribution System
- Anti Peptic Ulcer Drugs Distribution Channels
- Transportation and Freight Infrastructure
- Communications
- China's Market Entry
- Export to China
- Indirect Export
- Direct Export
- License and Contract Manufacture
- Assembling in China
- Contract Manufacturing
- Trade Permit
- Investment
- Equity Joint Venture
- Contractual Joint Venture
- Wholly Foreign-Owned Enterprise
VII. ANTIFREEZE & THAWING AGENT PRODUCER DIRECTORY
- Anti Dermatomycosis Skin Drugs Producer Profiles and Directory
